Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.
about
Diffusion imaging for therapy response assessment of brain tumorMonitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy.Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRIChanges in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy.Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.Application of 23Na MRI to monitor chemotherapeutic response in RIF-1 tumors.The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the boneSynergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer modelTemporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy.ADC response to radiation therapy correlates with induced changes in radiosensitivity.Magnetic resonance in the era of molecular imaging of cancerPredicting and monitoring cancer treatment response with diffusion-weighted MRI.Incorporation of diffusion-weighted magnetic resonance imaging data into a simple mathematical model of tumor growth.MRI of the tumor microenvironment.Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistanceMulti-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapyGene therapy progress and prospects: noninvasive imaging of gene therapy in living subjects.Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.The development and application of functional nuclear magnetic resonance to in vivo therapeutic anticancer research: 2002 Sir Godfrey Hounsfield lecture delivered at the President's Day, Manchester.DW-MRI as a Predictive Biomarker of Radiosensitization of GBM through Targeted Inhibition of Checkpoint Kinases.Short-interval estimation of proliferation rate using serial diffusion MRI predicts progression-free survival in newly diagnosed glioblastoma treated with radiochemotherapy.Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers.Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials.MRI detection of early bone metastases in b16 mouse melanoma models.Early gene therapy-induced apoptotic response in BT4C gliomas by magnetic resonance relaxation contrast T1 in the rotating frame.The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model.Combined QM(DFT)/MM molecular dynamics simulations of the deamination of cytosine by yeast cytosine deaminase (yCD).
P2860
Q30437277-43A0A82D-4641-4013-90FD-DDA7EAC927D0Q30673119-7E5B0DC0-518D-4407-AA5F-4C1607D84C6EQ30690776-BD0F7B6C-8E5F-4CB2-B9A0-A40794B0B2F4Q30930689-26696545-5E5F-4CB7-B6E4-00C30299D230Q30983132-D2BB05C9-FC27-44BE-B0BC-AB711CE8C1E6Q30986317-9E24FBD0-9EF7-4E92-A8C4-F11A820821D8Q30992467-E09F5168-784B-4A34-B472-476931BB2ECBQ30994994-EAC320BE-BBAF-4462-9188-CA2D8BBE42BCQ31043513-40D1865E-C6B5-484E-BC9F-4C07FA2F9B5EQ31140219-16373FD3-086F-4AE4-9B07-6DB3AC199536Q33414714-8B64600A-727B-4045-8F1E-FCD86DDD6AE7Q33492874-EFACA409-B844-4814-ABFA-0069217147D1Q33689750-F472104F-93F3-4FCB-B55E-4AB57E092C4AQ33883070-8E7D2B43-4036-413C-ACB2-35E9E789AE5EQ34052992-F0F4C109-D4EB-4211-8B9A-70256DABD11FQ34095962-34945334-649D-48CC-A60C-7EF230575041Q34918656-0C1D0694-ECA3-447F-B7F0-138572CBB7CBQ35119573-DBFCC904-1514-40CE-83D4-7D38FDE9E1D5Q35224703-8EA03FD9-B52A-4120-88AD-F978EB881F0DQ35623922-C582C105-C29D-4727-8A37-721230FE4CB1Q35698555-615DA091-4C07-4F19-9415-482C1BDE74F1Q35755404-13228629-3A0C-4C43-BCE8-C83C27310E51Q36723763-E0534C44-8863-4033-BB81-8049CF9EB916Q37640537-E0A4BAAE-E592-43AC-A5C8-94A8CD17A9C0Q39747261-B718BB97-35BF-4002-9FBD-B3A0D9507674Q40373403-0421711E-BB87-469F-9CA5-B2DA493686B0Q41687215-304C13B2-59A6-4ADA-8333-EFDACC81540AQ42020592-BC2609A5-3BE1-4E6B-B72C-545B2E7DA6A0Q43963738-D433B057-FAE1-4DEE-BB36-77F70E7E3163Q44038918-3F38D5F6-9C81-440C-B2FD-927FC5235948Q51545800-7F5BEAA8-7737-40DE-BDC5-D05C4292A8AD
P2860
Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Diffusion MRI detects early ev ...... aminase gene therapy strategy.
@ast
Diffusion MRI detects early ev ...... aminase gene therapy strategy.
@en
type
label
Diffusion MRI detects early ev ...... aminase gene therapy strategy.
@ast
Diffusion MRI detects early ev ...... aminase gene therapy strategy.
@en
prefLabel
Diffusion MRI detects early ev ...... aminase gene therapy strategy.
@ast
Diffusion MRI detects early ev ...... aminase gene therapy strategy.
@en
P2093
P2860
P356
P1433
P1476
Diffusion MRI detects early ev ...... aminase gene therapy strategy.
@en
P2093
A Rehemtulla
D A Hamstra
L D Stegman
T L Chenevert
P2860
P2888
P304
P356
10.1038/SJ.GT.3301199
P577
2000-06-01T00:00:00Z